相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction
Fabrizio Montecucco et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Regulation of Atherogenesis by Chemokines and Chemokine Receptors
Wuzhou Wan et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2013)
Fatty Acid Amide Hydrolase Deficiency Enhances Intraplaque Neutrophil Recruitment in Atherosclerotic Mice
Sebastien Lenglet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes
Oliver Soehnlein et al.
EMBO MOLECULAR MEDICINE (2013)
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice
Jean-Christophe Copin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Conditional Targeting of Tumor Necrosis Factor Receptor-Associated Factor 6 Reveals Opposing Functions of Toll-Like Receptor Signaling in Endothelial and Myeloid Cells in a Mouse Model of Atherosclerosis
Apostolos Polykratis et al.
CIRCULATION (2012)
Multiple Roles for Neutrophils in Atherosclerosis
Oliver Soehnlein
CIRCULATION RESEARCH (2012)
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques
Fabrizio Montecucco et al.
EUROPEAN HEART JOURNAL (2012)
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury
Emanuela Esposito et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Receptor activator of NF-kappa B ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability
Alessandra Quercioli et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Chemokines: established and novel targets in atherosclerosis
Rory R. Koenen et al.
EMBO MOLECULAR MEDICINE (2011)
A Key Role for Pre-B cell Colony-Enhancing Factor in Experimental Hepatitis
Alexander R. Moschen et al.
HEPATOLOGY (2011)
Atherosclerosis: current pathogenesis and therapeutic options
Christian Weber et al.
NATURE MEDICINE (2011)
Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice
Fabrizio Montecucco et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Maik Drechsler et al.
CIRCULATION (2010)
Therapeutic targeting of chemokine interactions in atherosclerosis
Rory R. Koenen et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke
Fabrizio Montecucco et al.
STROKE (2010)
NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway
Julia Skokowa et al.
NATURE MEDICINE (2009)
Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner
Frederic Van Gool et al.
NATURE MEDICINE (2009)
Catastrophic NAD+ Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE
Santina Bruzzone et al.
PLOS ONE (2009)
Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD
Nathalie Busso et al.
PLOS ONE (2008)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress
Caroline Cheng et al.
CIRCULATION (2006)
Up-regulated expression of the CXCR2 ligand KC/GRO-α in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression
WA Boisvert et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Anticancer agent CHS 828 suppresses nuclear factor-κB activity in cancer cells through downregulation of ikk activity
LS Olsen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A novel cycling assay for cellular cADP-ribose with nanomolar sensitivity
R Graeff et al.
BIOCHEMICAL JOURNAL (2002)